Cannabis has real, FDA-recognized human evidence in cancer care, and it is entirely about easing nausea and appetite, not about treating the cancer. Holding those two apart is the most important thing on this page.
What patients are managing
Cancer is a qualifying condition in Pennsylvania, including during remission therapy. Patients most often use cannabis for the collateral damage of treatment: the nausea, the appetite loss, the sleeplessness, the pain. That is a legitimate and well-trodden use. It is also completely separate from any question of whether cannabis acts on a tumor, and the two get blurred together constantly, usually not by accident.
What the research supports: cannabinoids
Here the human evidence is genuinely strong, and it is specific. Dronabinol and nabilone, both synthetic forms of THC, are FDA-approved for chemotherapy-induced nausea and vomiting when standard antiemetics fall short, and they perform as well as or better than several older drugs. For appetite and weight in advanced cancer, several small placebo-controlled trials of oral THC found improvement in one or more outcomes, a real if modest effect. This is the defensible, evidence-backed use of cannabinoids in cancer.
Worth knowing before you buyCannabis is not a cancer treatment. Anti-tumor effects have been seen only in cell and animal models and are unproven in humans, and no cannabis product has been shown to shrink, slow, or cure a cancer in a person. Choosing cannabis over your oncologist's plan is dangerous. The legitimate role is symptom support alongside treatment, nothing more.
What the research supports: terpenes
Even the strong evidence above is about cannabinoids, mostly single-molecule synthetic THC, not the terpene profile Terpenology reads off your label. For terpenes specifically, there is no human evidence for nausea, for appetite, or for any tumor outcome. Scattered cell and animal signals exist in the wider literature, but they are hypothesis-generating and irrelevant to what a product will do for you.
What the research does not support
No terpene has been shown to relieve nausea, restore appetite, or affect a cancer in any human trial. And nothing here, terpene or cannabinoid, treats the disease. The proven agents for symptoms are FDA-approved synthetic THC drugs, not strain terpenes. If any app shows you a confident cancer Fit score built on a terpene panel, it has crossed a line the evidence does not let it cross, and on this condition that line matters more than any other.
How Terpenology scores this
Terpenology scopes any cancer score explicitly to nausea and appetite symptom support, at moderate confidence, and it never presents anything that could be read as treating the cancer itself. The app makes clear that the proven symptom relief comes from cannabinoids rather than terpenes, and it pairs the score with a plain statement that cannabis is not a cancer treatment.
Terpenes worth reading about
Terpenology is educational, not medical advice. Terpene effects are tendencies commonly reported by patients and early research, never guaranteed outcomes. Nothing here is a substitute for the care of your certifying physician, your pharmacist, or the specialist treating your condition.